Back to Woodline Partners LP Woodline Partners LP

CLDXCLDX
18 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in Celldex Therapeutics, Inc.

Woodline Partners LP holds 700,830 shares of CLDX (Celldex Therapeutics, Inc.), worth $26.1M as of 2026-Q2. The position was increased (+40.1% shares). CLDX represents 0.1% of Woodline Partners LP's portfolio.

Current Value

$26.1M

Current Shares

700,830

Total Value Change

+$16M

Total Shares Change

+440,935

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
700,830
+40.1%
$26.1M0.1%$37.21
38
2026-Q1
Unchanged
500,127
0.0%
$15.9M0.1%$28.94
0
2025-Q4
Increased
500,127
+150.9%
$13.6M0.1%$26.43
45
2025-Q3
Decreased
199,291
-86.7%
$5.2M0.0%$26.19
0
2025-Q2
Increased
1.5M
+26.3%
$30.5M0.2%$20.29
43
2025-Q1
Decreased
1.2M
-41.0%
$21.6M0.1%$19.93
0
2024-Q4
Decreased
2M
-14.0%
$50.9M0.3%$25.12
0
2024-Q3
Increased
2.3M
+208.9%
$79.6M0.7%$33.20
68
2024-Q2
Increased
757,771
+0.9%
$28M0.3%$37.01
35
2024-Q1
Increased
751,060
+93.8%
$31.5M0.3%$41.97
55
2023-Q4
Increased
387,652
+260.6%
$15.4M0.2%$39.66
54
2023-Q3
Increased
107,496
+97.2%
$3M0.0%$27.52
42
2023-Q2
Decreased
54,499
-1.8%
$1.8M0.0%$34.58
0
2023-Q1
New
55,471
-
$2M0.0%$35.58
36
2022-Q3
Exited
0
-100.0%
$00.0%$28.35
0
2022-Q2
Decreased
64,454
-88.9%
$1.7M0.0%$27.83
0
2022-Q1
Increased
579,192
+122.9%
$19.7M0.3%$34.59
55
2021-Q4
New
259,895
-
$10M0.1%$38.90
46

Other major holders of CLDX: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used